For research use only. Not for therapeutic Use.
Distigmine Bromide (CAT: R014940) is a medication used to treat conditions characterized by muscle weakness or dysfunction, such as myasthenia gravis. It functions as a reversible acetylcholinesterase inhibitor, preventing the breakdown of acetylcholine, a neurotransmitter crucial for muscle function. By increasing the availability of acetylcholine at the neuromuscular junction, Distigmine Bromide helps improve muscle strength and contraction.
Catalog Number | R014940 |
CAS Number | 15876-67-2 |
Synonyms | Hexamethylenebis[methylcarbamate] 3-Hydroxy-1-methylpyridinium Bromide; 3,3’-[1,6-Hexanediylbis[(methylimino)carbonyl]oxy]bis[1-methyl-pyridinium Dibromide; BC 51; Distigmine Dibromide; Hexamarium; N,N’-Hexamethylenebis(3-N-methylcarbamoxy-1-methylpy |
Molecular Formula | C22H32Br2N4O4 |
Purity | ≥95% |
Target | Cholinesterase (ChE) |
Storage | -20°C |
IUPAC Name | (1-methylpyridin-1-ium-3-yl) N-methyl-N-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate;dibromide |
InChI | InChI=1S/C22H32N4O4.2BrH/c1-23-13-9-11-19(17-23)29-21(27)25(3)15-7-5-6-8-16-26(4)22(28)30-20-12-10-14-24(2)18-20;;/h9-14,17-18H,5-8,15-16H2,1-4H3;2*1H/q+2;;/p-2 |
InChIKey | GJHSNEVFXQVOHR-UHFFFAOYSA-L |
SMILES | C[N+]1=CC=CC(=C1)OC(=O)N(C)CCCCCCN(C)C(=O)OC2=C[N+](=CC=C2)C.[Br-].[Br-] |
Reference | <span style=”color:#000000;”><span style=”font-size:12px;”><span style=”font-family:arial,helvetica,sans-serif;”>1.Kobayashi, Kazuki, et al. "Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment." <i style=”font-family: Arial, sans-serif; font-size: 13px;”>Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi= The Japanese journal of toxicology</i> 29.1 (2016): 26-29.<br /> |